Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap5.12B
Enterprise Value3.71B
P/E Ratio18.57
PEG Ratio0.26
Price/Sales Ratio5.25
Price/Book Ratio1.7
Enterprise/Revenue3.83
Enterprise/EBITDA10.73

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.29
Operating Margin0.31
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.09

Income Statement

Revenue1.05B
Revenue/Share2.51
Gross Profit653.4M
EBITDA309.43M
Net Income272.54M
Diluted EPS0.71

Balance Sheet

Total Cash2.13B
Total Cash/Share5.48
Total Debt3.06M
Total Debt/Equity0
Current Ratio6.55
Book Value Per Share7.86

Price History

52-Week Change-49.84
52-Week High20.82
52-Week Low7.7
Moving Average 50 Days8.81
Moving Average 200 Days11.78

Statistics

Average Volume735,307
Shares Outstanding595.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.36
Trailing Annual Dividend Yield2.69
Payout Ratio0.73
Last Split Factor5:2
Last Split DateApril 20, 2020
AD